Nicolas Hubacz: How Psychoactive Drugs Alter Spider Web Construction
Nicolas Hubacz, Research and Clinical Products Business Development Manager at Magstim, shared a post on LinkedIn:
“How Psychoactive Drugs Alter Spider Web Construction
In 1995, scientists explored how different drugs influence spider web construction to understand their impact on behavior and motor skills. This research was initiated due to a zoologist’s request to alter the time garden spiders build their webs. The team administered various psychoactive substances, such as amphetamine, mescaline, strychnine, LSD, and caffeine, observing changes in web size and shape rather than timing.
Low caffeine doses led to smaller webs with uneven radii, while higher doses resulted in even smaller, irregular designs. Each drug induced different effects: sleeping pills caused drowsiness and incomplete webs, Benzedrine created zigzag patterns, marijuana resulted in missing inner sections, and scopolamine disrupted directional sense.
The study highlighted how drugs affect spider behavior, offering insights into the broader impacts of psychoactive substances across species.”
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS